Department of Chemistry and Biochemistry , Concordia University , Montreal , QC , Canada H4B 1R6.
Precision NanoSystems, Vancouver , BC , Canada V6T 1Z3.
Langmuir. 2018 Mar 13;34(10):3316-3325. doi: 10.1021/acs.langmuir.8b00338. Epub 2018 Mar 2.
Controlling the size and narrow size distribution of polymer-based nanocarriers for targeted drug delivery is an important parameter that significantly influences their colloidal stability, biodistribution, and targeting ability. Herein, we report a high-throughput microfluidic process to fabricate colloidally stable aqueous nanoparticulate colloids with tunable sizes at 50-150 nm and narrow size distribution. The nanoparticulates are designed with different molecular weight polyesters having both ester bonds (responsive to esterase) and sulfide linkages (to oxidative reaction) on the backbones, thus exhibiting dual esterase/oxidation responses, causing the destabilization of the nanoparticulates to lead to the controlled release of encapsulated therapeutics. The systematic investigation on both microfluidic and formulation parameters enables to control their properties as allowing for decreasing nanoparticulate sizes as well as improving colloidal stability and cytotoxicity. Further to such control over smaller size and narrow size distribution, dual stimuli-responsive degradation and excellent cellular uptake could suggest that the microfluidic nanoparticulates stabilized with polymeric stabilizers could offer the versatility toward dual smart drug delivery exhibiting enhanced release kinetics.
控制基于聚合物的纳米载体的尺寸和窄尺寸分布,以实现靶向药物输送,是一个重要的参数,它显著影响纳米载体的胶体稳定性、生物分布和靶向能力。在此,我们报告了一种高通量微流控工艺,用于制备胶体稳定的水性纳米颗粒胶体,其尺寸可在 50-150nm 之间调节,且尺寸分布较窄。纳米颗粒的设计采用了不同分子量的聚酯,其主链上既有酯键(对酯酶有反应)又有硫醚键(对氧化反应有反应),因此表现出双重酯酶/氧化反应,导致纳米颗粒的失稳,从而实现包封治疗剂的控制释放。对微流控和配方参数的系统研究能够控制其性能,使纳米颗粒的尺寸减小,胶体稳定性和细胞毒性提高。通过对更小的尺寸和更窄的尺寸分布的控制,双重刺激响应降解和优异的细胞摄取表明,用聚合物稳定剂稳定的微流控纳米颗粒可以提供多功能性,用于表现出增强的释放动力学的双重智能药物输送。